Black Sea Journal of Health Science

Black Sea Journal of Health Science

Antiviral Tedavi Almadan Spontan İyileşen Astım ve COVID 19 Pnömolili Hastanın Üç Aylık Takibi

Yazarlar: Işıl ALIRAVCI, Cemile ÇETİNKAYA, Sevil ALKAN ÇEVİKER

Cilt 4 , Sayı 2 , 2021 , Sayfalar 150 - 152

Konular:Genel ve Dahili Tıp

DOI:10.19127/bshealthscience.796210

Anahtar Kelimeler:Asthma,COVID 19,Pneumonia

Özet: 2019 new coronavirus disease (COVID-19) has emerged due to severe acute respiratory syndrome coronavirus (SARS-CoV-2), after it was first reported in Wuhan province of China, it spread all over the world. During the clinical course of the new type of coronavirus disease, symptoms can detected such as headache, fatigue and shortness of breath are the most commons, as well as fever and cough. There is limited data in the literature regarding the follow-up of COVID 19 in asthmatic patients. In addition, there is not enough information about this disease, which has recently entered our daily life, at the level of guidance worldwide. In this case report; It is aimed to present a three-month clinical follow-up of the patient who was diagnosed with asthma and COVID 19 and recovered without any sequelae on thoracic tomography despite not receiving antiviral therapy.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2021, title={Antiviral Tedavi Almadan Spontan İyileşen Astım ve COVID 19 Pnömolili Hastanın Üç Aylık Takibi}, volume={4}, number={150–152}, publisher={Black Sea Journal of Health Science}, author={Işıl ALIRAVCI,Cemile ÇETİNKAYA,Sevil ALKAN ÇEVİKER}, year={2021} }
APA
KOPYALA
Işıl ALIRAVCI,Cemile ÇETİNKAYA,Sevil ALKAN ÇEVİKER. (2021). Antiviral Tedavi Almadan Spontan İyileşen Astım ve COVID 19 Pnömolili Hastanın Üç Aylık Takibi (Vol. 4). Vol. 4. Black Sea Journal of Health Science.
MLA
KOPYALA
Işıl ALIRAVCI,Cemile ÇETİNKAYA,Sevil ALKAN ÇEVİKER. Antiviral Tedavi Almadan Spontan İyileşen Astım ve COVID 19 Pnömolili Hastanın Üç Aylık Takibi. no. 150–152, Black Sea Journal of Health Science, 2021.